Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
AUPH Quote, Financials, Valuation and Earnings
Last price:
$9.08
Seasonality move
:
-5.15%
Day range:
$8.84 - $9.19
52-week range:
$5.20 - $10.67
Dividend yield:
0%
P/E ratio:
31.61x
P/S ratio:
5.18x
P/B ratio:
3.41x
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
52.59%
Market cap:
$1.2B
Revenue:
$235.1M
EPS (TTM):
$0.28
Earnings Data
Next earnings date for AUPH
Aug 01
2025
Most recent earnings per share
$0.16
Beat by $0.06
(May 12/2025)
Consensus Estimate
$0.10
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AUPH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $64.5M | -- | -- | $0.14 | -- |
| 08/01/2025 | Q2 | $64.3M | -- | -- | $0.14 | -- |
| 05/12/2025 | Q1 | $61.1M | $62.5M | $0.16 | $0.10 | $0.06 |
| 02/27/2025 | Q4 | $59.9M | $59.9M | $0.01 | -$0.02 | $0.03 |
| 11/07/2024 | Q3 | $57.7M | $67.8M | $0.10 | $0.02 | $0.09 |
| 08/01/2024 | Q2 | $54.7M | $57.2M | $0.01 | $0.01 | $0.00 |
| 05/02/2024 | Q1 | $47.1M | $50.3M | -$0.07 | -$0.14 | $0.07 |
| 02/15/2024 | Q4 | $45.2M | $45.1M | -$0.18 | -$0.16 | -$0.02 |
| 11/02/2023 | Q3 | $38.5M | $54.5M | -$0.09 | -$0.17 | $0.08 |
| 08/03/2023 | Q2 | $37.5M | $41.5M | -$0.08 | -$0.19 | $0.11 |
| 05/04/2023 | Q1 | $28.1M | $34.4M | -$0.18 | -$0.22 | $0.04 |
| 02/28/2023 | Q4 | -- | $28.4M | -$0.18 | -- | -- |
| 11/03/2022 | Q3 | -- | $55.8M | -$0.06 | -- | -- |
| 08/04/2022 | Q2 | -- | $28.2M | -$0.25 | -- | -- |
| 05/10/2022 | Q1 | -- | $21.6M | -$0.27 | -- | -- |
| 02/28/2022 | Q4 | -- | $23.4M | -$0.25 | -- | -- |
| 11/03/2021 | Q3 | -- | $14.7M | -$0.39 | -- | -- |
| 08/05/2021 | Q2 | -- | $6.6M | -$0.37 | -- | -- |
| 05/06/2021 | Q1 | -- | $914K | -$0.40 | -- | -- |
| 02/24/2021 | Q4 | -- | $50M | -$0.05 | -- | -- |
| 11/10/2020 | Q3 | -- | $29K | -$0.34 | -- | -- |
| 08/11/2020 | Q2 | -- | $29K | -$0.24 | -- | -- |
| 05/14/2020 | Q1 | -- | $30K | -$0.23 | -- | -- |
| 03/05/2020 | Q4 | -- | $29K | -$0.78 | -- | -- |
| 11/14/2019 | Q3 | -- | $230K | -$0.21 | -- | -- |
| 08/06/2019 | Q2 | -- | $29K | -$0.17 | -- | -- |
| 05/14/2019 | Q1 | -- | $30K | -$0.14 | -- | -- |
| 03/19/2019 | Q4 | -- | $29K | -$0.17 | -- | -- |
| 11/08/2018 | Q3 | -- | $375K | -$0.21 | -- | -- |
| 08/09/2018 | Q2 | -- | $29K | -$0.19 | -- | -- |
| 05/10/2018 | Q1 | -- | $30K | -$0.18 | -- | -- |
| 03/15/2018 | Q4 | -- | $30K | -$0.04 | -- | -- |
| 11/14/2017 | Q3 | -- | $29K | -$0.16 | -- | -- |
| 08/10/2017 | Q2 | -- | $329K | -$0.03 | -- | -- |
| 05/15/2017 | Q1 | -- | $30K | -$0.92 | -- | -- |
| 03/09/2017 | Q4 | -- | $30K | -$0.22 | -- | -- |
| 11/04/2016 | Q3 | -- | $31K | -$0.21 | -- | -- |
| 08/05/2016 | Q2 | -- | $55K | -$0.10 | -- | -- |
| 05/20/2016 | Q1 | -- | $57K | -$0.13 | -- | -- |
| 12/31/2015 | Q4 | -- | $57K | -$0.13 | -- | -- |
| 11/11/2015 | Q3 | -- | $57K | -$0.16 | -- | -- |
Aurinia Pharmaceuticals Earnings Questions
-
How Much did Aurinia Pharmaceuticals Generate in Revenue Last Quarter?
Aurinia Pharmaceuticals reported $62.5M worth of top line sales in its most recent quarter.
-
Did Aurinia Pharmaceuticals Beat Earnings Last Quarter?
Aurinia Pharmaceuticals announced earnings per share of $0.16 which represents a beat of analyst forecast a $0.10 per share.
-
Is Aurinia Pharmaceuticals Profitable?
Aurinia Pharmaceuticals reported $53.9M that represents $0.39 per share over the last quarter.
-
What is the Analyst Consensus for Aurinia Pharmaceuticals EPS Next Year?
Aurinia Pharmaceuticals's earnings are forecast to grow from $0.04 per share to $0.03 per share next year representing an increase of 1365%.
-
When is Aurinia Pharmaceuticals's Earnings Date?
Aurinia Pharmaceuticals's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
